Physicians really should look at irrespective of whether their sufferers with underlying NAION threat variables can be adversely afflicted by utilization of PDE5 inhibitors. Individuals who have now skilled NAION are at amplified threat of NAION recurrence. Consequently, PDE5 inhibitors, such as LEVITRA, ought to be applied with warning in these pe